Introduction: Glucocorticoids are the only drugs available for the treatment of Duchenne muscular dystrophy (DMD), but it is unclear whether their efficacy is dependent on their anti-inflammatory activity. Methods: To address this issue, mdx mice were treated daily with methylprednisolone and non-steroidal anti-inflammatory drugs (NSAIDs: aspirin, ibuprofen, parecoxib). Results: NSAID treatment was effective in ameliorating muscle morphology and reducing macrophage infiltration and necrosis. The percentage of regenerating myofibers was not modified by the treatments. The drugs were effective in reducing COX-2 expression and inflammatory cytokines, but they did not affect utrophin levels. The effects of the treatments on contractile performance were analyzed. Isometric tension did not differ in treated and untreated muscle, but the resistance to fatigue was decreased by treatment with methylprednisolone and aspirin. Conclusions: NSAIDs have a beneficial effect on mdx muscle morphology, pointing to a crucial role of inflammation in the progression of DMD. Muscle Nerve, 2012

Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs / Filippo, Serra; Marco, Quarta; Marta, Canato; Luana, Toniolo; DE ARCANGELIS, Valeria; Attilio, Trotta; Lucia, Spath; Monaco, Lucia; Carlo, Reggiani; Naro, Fabio. - In: MUSCLE & NERVE. - ISSN 0148-639X. - STAMPA. - 46:5(2012), pp. 773-784. [10.1002/mus.23432]

Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs

DE ARCANGELIS, VALERIA;MONACO, Lucia;NARO, Fabio
2012

Abstract

Introduction: Glucocorticoids are the only drugs available for the treatment of Duchenne muscular dystrophy (DMD), but it is unclear whether their efficacy is dependent on their anti-inflammatory activity. Methods: To address this issue, mdx mice were treated daily with methylprednisolone and non-steroidal anti-inflammatory drugs (NSAIDs: aspirin, ibuprofen, parecoxib). Results: NSAID treatment was effective in ameliorating muscle morphology and reducing macrophage infiltration and necrosis. The percentage of regenerating myofibers was not modified by the treatments. The drugs were effective in reducing COX-2 expression and inflammatory cytokines, but they did not affect utrophin levels. The effects of the treatments on contractile performance were analyzed. Isometric tension did not differ in treated and untreated muscle, but the resistance to fatigue was decreased by treatment with methylprednisolone and aspirin. Conclusions: NSAIDs have a beneficial effect on mdx muscle morphology, pointing to a crucial role of inflammation in the progression of DMD. Muscle Nerve, 2012
2012
glucocorticoids; inflammation; non-steroidal anti-inflammatory drugs; muscular dystrophy; cox
01 Pubblicazione su rivista::01a Articolo in rivista
Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs / Filippo, Serra; Marco, Quarta; Marta, Canato; Luana, Toniolo; DE ARCANGELIS, Valeria; Attilio, Trotta; Lucia, Spath; Monaco, Lucia; Carlo, Reggiani; Naro, Fabio. - In: MUSCLE & NERVE. - ISSN 0148-639X. - STAMPA. - 46:5(2012), pp. 773-784. [10.1002/mus.23432]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/472712
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 38
social impact